Daniel P. van Plew Net Worth & Insider Trades

Daniel P. van Plew - EVP & General Mgr, Regeneron Pharmaceuticals, Inc

As of November 25, 2022

What is Daniel P. van Plew's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals, Inc's EVP & General Mgr, Daniel P. van Plew, is estimated to be about $139.09M . Daniel P. van Plew owns about 31,643 units of Regeneron Pharmaceuticals, Inc common stock. In the last 15 years at Regeneron Pharmaceuticals, Inc, Daniel P. van Plew has sold an estimated value of $340.28M worth.

What is Daniel P. van Plew's Past Insider Trading?

Daniel P. van Plew's largest purchase order was 40,000 units , worth over $22.23M on September 13, 2022. Daniel P. van Plew's largest sale order was 85,579 units , worth over $47.9M on May 8, 2020. In total, Daniel P. van Plew has made about 43 transactions over 15 years of their time at Regeneron Pharmaceuticals, Inc. Daniel P. van Plew usually trades in December, with the busiest year in 2014 and 2020. The most recent transaction was a sale order of 50,000 units , worth over $37.08M on November 25, 2022.

Daniel P. Van Plew

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Daniel P. van Plew's Salary in 2020?

As EVP & General Mgr of Regeneron Pharmaceuticals, Inc, Daniel P. van Plew has a total base salary of $825,577 . Daniel P. van Plew received compensation valued at about $8,654,453 in 2020 after becoming EVP & General Mgr. The vast majority of their compensation came in the form of stock awards of $3,409,560 , other earnings, plans or compensations of $938,872 , other earnings, plans or compensations of $938,872 , and other compensation of $20,945 .

What is Daniel P. van Plew's' Mailing Address?

  • Mailing address is Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 NY

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?

Regeneron Pharmaceuticals, Inc's most recent insider trade came on November 25, 2022 by Daniel P. van Plew who sold 50,000 units worth $37.08M . In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.48B and bought an estimated value of $3.51B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1